Verastem (NASDAQ:VSTM – Get Free Report) had its price target increased by equities researchers at Guggenheim from $13.00 to $14.00 in a report issued on Monday,Benzinga reports. The firm currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback